What brain regions are involved in psychiatric disorders and how do they affect the brain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brain Regions Involved in Psychiatric Disorders: A Neuroanatomical Guide for Psychiatric Nurse Practitioners

Core Neural Circuits in Psychiatric Disorders

Psychiatric disorders arise from dysfunction in specific brain circuits rather than isolated regions, with cortico-striato-thalamo-cortical (CSTC) loops and frontolimbic networks being the primary pathways affected across most major psychiatric conditions. 1

Primary Circuit Systems

Cortico-Striato-Thalamo-Cortical (CSTC) Circuits - These parallel, partly segregated loops connect cortical regions through the basal ganglia and thalamus back to cortex, mediating sensorimotor, cognitive, affective, and motivational processes 1:

  • Sensorimotor CSTC Circuit: Involves supplementary motor area (SMA), pre-SMA, and posterior putamen; controls stimulus-response-based habitual behaviors 1
  • Dorsal Cognitive CSTC Circuit: Connects dorsolateral prefrontal cortex (dlPFC), dorsomedial prefrontal cortex (dmPFC), and dorsal caudate; coordinates cognitive control, working memory, planning, and emotion regulation 1
  • Ventral Motivational CSTC Circuit: Links orbitofrontal cortex (OFC), ventromedial prefrontal cortex (vmPFC), ventral caudate, and nucleus accumbens; governs stimulus-outcome-based motivational behavior 1

Frontolimbic Circuit - Connects prefrontal regions with amygdala and other limbic structures; critical for fear extinction and emotional processing 1

Specific Brain Regions and Their Psychiatric Functions

Prefrontal Cortex Subdivisions

  • Dorsolateral Prefrontal Cortex (dlPFC): Executive function, working memory, cognitive flexibility; dysfunction linked to schizophrenia, depression, and ADHD 1
  • Dorsomedial Prefrontal Cortex (dmPFC): Self-referential processing, emotion regulation; implicated in mood and anxiety disorders 1
  • Ventrolateral Prefrontal Cortex (vlPFC): Response inhibition, impulse control; disrupted in OCD and ADHD 1
  • Orbitofrontal Cortex (OFC): Reward processing, decision-making, social cognition; abnormal in OCD, addiction, and antisocial behavior 1
  • Ventromedial Prefrontal Cortex (vmPFC): Emotional valuation, fear extinction, moral reasoning; affected in depression, PTSD, and behavioral variant frontotemporal dementia 1

Basal Ganglia Components

  • Dorsal Caudate: Goal-directed behavior, cognitive control; hyperactive in OCD 1
  • Ventral Caudate: Motivational processing; disrupted in depression and addiction 1
  • Posterior Putamen: Motor habits, compulsive behaviors; overactive in OCD 1
  • Nucleus Accumbens: Reward processing, motivation; dysfunctional in depression, addiction, and schizophrenia 1

Limbic System Structures

  • Amygdala: Fear processing, threat detection, emotional memory; hyperactive in anxiety disorders and PTSD, hypoactive in psychopathy 1
  • Hippocampus: Memory consolidation, contextual processing; reduced volume in depression, PTSD, and schizophrenia 1

Motor and Premotor Areas

  • Supplementary Motor Area (SMA) and Pre-SMA: Motor planning, action selection; involved in compulsive behaviors and tic disorders 1

Subcortical Structures

  • Thalamus: Relay station for sensory and motor information; disrupted connectivity in schizophrenia and OCD 1
  • Cerebellum: Motor coordination, cognitive processing, fear extinction; increasingly recognized in psychiatric disorders 1

Disorder-Specific Circuit Dysfunction

Obsessive-Compulsive Disorder (OCD)

OCD involves hyperactivity in the sensorimotor CSTC circuit driving habitual compulsive behaviors, combined with ventral motivational circuit dysfunction causing anxiety and uncertainty with goal-directed behaviors 1:

  • Increased activity: OFC, anterior cingulate cortex, caudate, putamen 1
  • Frontolimbic circuit impairment affects fear extinction 1
  • Frontoparietal network dysfunction impairs cognitive control 1

Depression and Mood Disorders

Depression involves hypoactivity in dorsal cognitive circuits (dlPFC, dmPFC) and hyperactivity in ventral motivational circuits (vmPFC, amygdala, nucleus accumbens), creating an imbalance between cognitive control and emotional reactivity 1

Schizophrenia

Schizophrenia demonstrates widespread CSTC circuit dysfunction with dopaminergic hyperactivity in mesolimbic pathways (nucleus accumbens) causing positive symptoms, and hypoactivity in mesocortical pathways (dlPFC) causing negative symptoms and cognitive deficits 1

Behavioral Variant Frontotemporal Dementia (bvFTD)

bvFTD shows progressive degeneration of vmPFC, OFC, and anterior temporal regions, causing severe deficits in social cognition, emotion recognition, theory of mind, empathy, and moral reasoning 1:

  • Distinguishable from primary psychiatric disorders by progressive neurodegeneration on neuroimaging 1
  • Social cognition impairment more severe than in major psychiatric disorders 1

Critical Diagnostic Considerations

Medical Conditions Mimicking Psychiatric Disorders

Before attributing symptoms to primary psychiatric illness, rule out neurological and systemic conditions that present with psychiatric symptoms 1:

Neurological causes requiring immediate evaluation:

  • Stroke, intracranial hemorrhage, CNS tumors, CNS infections (meningitis, encephalitis, HIV, syphilis) 1
  • Seizures, hydrocephalus, traumatic brain injury 1
  • Neurodegenerative disorders (multiple sclerosis, Huntington chorea) 1

Metabolic/endocrine causes:

  • Hyponatremia, hypocalcemia, hypoglycemia, hyperglycemia, ketoacidosis, uremia 1
  • Thyroid disease (hyperthyroidism, hypothyroidism), adrenal disease (Addison, Cushing), pheochromocytoma 1

Medication-induced causes:

  • Drug withdrawal (alcohol, benzodiazepines, barbiturates) or intoxication 1
  • Prescription medications (steroids, anticholinergics, cardiac medications) 1

When to Order Neuroimaging

Routine brain CT or MRI is NOT indicated for psychiatric presentations with normal vital signs, alert mental status, cooperative behavior, and noncontributory history and physical examination 1:

  • Brain imaging has extremely low yield (1.2-5%) in new-onset psychosis without focal neurologic findings 1
  • Order neuroimaging only when: altered mental status, abnormal vital signs, focal neurologic signs, new-onset symptoms with acute changes, or concerning findings on neurologic examination 1
  • Pediatric patients require additional caution due to radiation exposure concerns 1

Essential Physical Examination Components

Focus neurologic examination on detecting underlying medical conditions 1:

  • Vital signs abnormalities (fever, tachycardia, hypertension, hypotension) 1
  • Complete neurologic examination including cranial nerves, motor strength, sensory function, reflexes, coordination, gait 1
  • Cardiac and respiratory system assessment 1
  • Signs of head trauma, infection, or systemic illness 1

Functional Connectivity and Network Approaches

Modern neuroimaging reveals that psychiatric disorders involve disrupted functional connectivity between brain regions rather than isolated structural abnormalities 1:

  • Functional networks (default-mode, salience, executive control) show altered connectivity patterns in psychiatric disorders 1
  • Machine learning approaches can identify connectivity patterns distinguishing diagnostic groups, though clinical utility remains limited 1
  • Head motion during scanning significantly confounds functional connectivity results and must be adequately controlled 1

Molecular and Neurotransmitter Systems

While circuit-based models provide anatomical frameworks, neurotransmitter systems modulate these circuits 1, 2:

  • Dopamine: Mesolimbic and mesocortical pathways affected in schizophrenia and addiction 1
  • Serotonin: Widespread projections from raphe nuclei; targeted by SSRIs for depression, anxiety, and OCD 1
  • Norepinephrine: Locus coeruleus projections; involved in attention, arousal, and mood regulation 1
  • Glutamate: Primary excitatory neurotransmitter; emerging target in treatment-resistant OCD 3
  • GABA: Primary inhibitory neurotransmitter; implicated in anxiety disorders 1

Clinical Implications for Treatment

Understanding circuit dysfunction guides treatment selection 1, 3:

  • Medications target neurotransmitter systems modulating dysfunctional circuits 1
  • Cognitive-behavioral therapy with exposure and response prevention directly modifies CSTC circuit activity in OCD 3
  • Neuromodulation techniques (rTMS, DBS) directly target specific brain regions within dysfunctional circuits 3
  • Treatment resistance may reflect inadequate circuit modulation requiring augmentation strategies or alternative approaches 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Molecular mechanisms of psychiatric diseases.

Neurobiology of disease, 2020

Guideline

Treatment of Treatment-Resistant OCD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended approach for determining if there is an underlying psychiatric disorder in adults presenting for a psychiatric evaluation?
What is the comprehensive approach to diagnosing disorders?
Do you need to consider the nature and degree of a mental disorder when sectioning someone under Section 2 (Mental Health Act)?
How do psychiatrists determine if a presenting symptom is a defining or associated feature of a mental disorder?
What is the definition of a mental disorder?
What is the role of brain chemicals, such as neurotransmitters (e.g. serotonin, norepinephrine, dopamine, gamma-aminobutyric acid (GABA)), in various psychiatric illnesses, including depression, anxiety disorders, bipolar disorder, and schizophrenia, and how do medications like Selective Serotonin Reuptake Inhibitors (SSRIs) (e.g. fluoxetine (Prozac), sertraline (Zoloft)), benzodiazepines (e.g. alprazolam (Xanax), clonazepam (Klonopin)), mood stabilizers (e.g. lithium, valproate (Depakote)), and antipsychotics (e.g. risperidone (Risperdal), olanzapine (Zyprexa)) affect these chemicals to alleviate symptoms?
At what age should a Dual-Energy X-ray Absorptiometry (DXA) scan be started, and is it exclusive to females?
What is a suitable medication option to administer at night for a patient with hypertension (high blood pressure) that is elevated in the morning?
What are the next steps for an adult male over 50 with elevated Prostate-Specific Antigen (PSA) levels?
What simple therapy techniques can Psychiatric Nurse Practitioners (Psych NPs) use during patient sessions to manage anxiety, depression, and trauma?
Can a patient with a potential diagnosis of prostate cancer, considering their age, overall health, and medical history, remove their prostate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.